ARROWHEAD PHARMACEUTICALS, INC.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
Javier San Martin, M.D., the Chief Medical Officer of Arrowhead Pharmaceuticals, Inc. (the “Company”), will be leaving the Company, effective as of February 1, 2024.
Bruce Given, M.D., who previously served as the Company's Chief Operating Officer and head of Research and Development until his retirement on May 1, 2020, will assist the Company in the orderly transition of Dr. San Martin's departure in Dr. Given’s new role as Chief Medical Scientist.
Extracted from this filing and checked against the source text.
Javier San Martin departed as Chief Medical Officer at ARROWHEAD PHARMACEUTICALS, INC..
Javier San Martin, M.D., the Chief Medical Officer of Arrowhead Pharmaceuticals, Inc. (the “Company”), will be leaving the Company, effective as of February 1, 2024.View on SEC.gov
Bruce Given was appointed as Chief Medical Scientist at ARROWHEAD PHARMACEUTICALS, INC..
Bruce Given, M.D., who previously served as the Company's Chief Operating Officer and head of Research and Development until his retirement on May 1, 2020, will assist the Company in the orderly transition of Dr. San Martin's departure in Dr. Given’s new role as Chief Medical Scientist.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.